Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BONESUPPORT HOLDING AB ( (SE:BONEX) ) just unveiled an update.
BONESUPPORT announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has approved CERAMENT G for a New Technology Add-On Payment (NTAP) for treating open fractures, effective October 1, 2025. This approval allows hospitals to receive additional reimbursement, potentially impacting the company’s market presence and offering financial benefits to healthcare providers using their products.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a company based in Lund, Sweden, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and can elute drugs. The company is recognized for its patented technology platform and conducts clinical studies to demonstrate the clinical and economic benefits of its products.
Average Trading Volume: 191,426
Technical Sentiment Signal: Buy
Current Market Cap: SEK20.44B
For a thorough assessment of BONEX stock, go to TipRanks’ Stock Analysis page.